Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium

Stocktwits·Nov 13

This story is reported by Stocktwits. Read what other outlets are saying below, then open the original report for full details.